Cognizant(CTSH)

Search documents
Cognizant (CTSH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
ZACKS· 2024-10-30 22:31
For the quarter ended September 2024, Cognizant (CTSH) reported revenue of $5.04 billion, up 3% over the same period last year. EPS came in at $1.25, compared to $1.16 in the year-ago quarter.The reported revenue represents a surprise of +0.82% over the Zacks Consensus Estimate of $5 billion. With the consensus EPS estimate being $1.14, the EPS surprise was +9.65%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectati ...
Cognizant (CTSH) Q3 Earnings and Revenues Beat Estimates
ZACKS· 2024-10-30 22:15
Cognizant (CTSH) came out with quarterly earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $1.16 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 9.65%. A quarter ago, it was expected that this information technology consulting and outsourcing firm would post earnings of $1.12 per share when it actually produced earnings of $1.17, delivering a surprise of 4.46%.Ov ...
Cognizant(CTSH) - 2024 Q3 - Quarterly Report
2024-10-30 21:45
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2024 ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 0-24429 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware 13-372835 ...
Cognizant(CTSH) - 2024 Q3 - Quarterly Results
2024-10-30 20:04
Exhibit 99.1 Cognizant Reports Third Quarter 2024 Results 1 • Revenue of $5.0 billion, increased 3.0% year-over-year or 2.7% in constant currency , the high end of our guidance ranges • Operating margin of 14.6%, sequentially flat and increased 60 basis points year-over-year; year-to-date operating margin of 14.6%, increased 110 basis points year-over-year • Adjusted Operating Margin of 15.3%, increased 10 basis points sequentially and decreased 20 basis points year-over-year; year-to-date Adjusted Operatin ...
Cognizant Reports Third Quarter 2024 Results
Prnewswire· 2024-10-30 20:01
Revenue of $5.0 billion, increased 3.0% year-over-year or 2.7% in constant currency1, the high end of our guidance ranges Operating margin of 14.6%, sequentially flat and increased 60 basis points year-over-year; year-to-date operating margin of 14.6%, increased 110 basis points year-over-year Adjusted Operating Margin1 of 15.3%, increased 10 basis points sequentially and decreased 20 basis points year-over-year; year-to-date Adjusted Operating Margin of 15.2%, increased 40 basis points year-over-year Trai ...
Cognizant's Synapse Skilling Initiative Impacts More Than 275,000 Individuals in its First Year
Prnewswire· 2024-10-29 18:59
Launched about one year ago, Cognizant created Synapse as a global program to equip individuals with the technology skills they need to be part of the workforce of the future. TEANECK, N.J., Oct. 29, 2024 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced it has reached more than 275,000 people via its global skilling initiative, Synapse, which launched one year ago in October, 2023. This milestone shows Cognizant is more than a quarter of the way toward reaching the program's goal to advance technolo ...
Cognizant Collaborates with Alnylam as Technology Services Partner to Scale IT Operations
Prnewswire· 2024-10-29 16:00
Utilizing Cognizant's top-tier managed services frameworks and tools, the partnership aims to enhance Alnylam's automation and reduce operational effortsTEANECK, N.J., Oct. 29, 2024 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) announced today a new agreement with Alnylam Pharmaceuticals, Inc., a leading biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics. Cognizant will serve as an integral IT Managed Services provider for Alnylam. This collaboration aims to scale Alnylam's IT oper ...
Cognizant Signs Strategic Collaboration Agreement with AWS to Empower the Digital Factory and Enhance Smart Manufacturing
Prnewswire· 2024-10-29 13:00
Cognizant and AWS to bring generative AI-powered offerings to market to transform manufacturing operations at scale, for enterprises in industrial, automotive, life sciences and consumer goods industries TEANECK, N.J., Oct. 29, 2024 /PRNewswire/ -- Cognizant (NASDAQ:CTSH) announced today that it has signed a strategic collaboration agreement (SCA) with Amazon Web Services (AWS), with plans to deliver advanced technology solutions and cloud computing services, focused on enhancing smart manufacturing capabil ...
Cognizant Set to Report Q3 Earnings: What's in Store for the Stock?
ZACKS· 2024-10-28 18:36
Cognizant Technology Solutions (CTSH) is scheduled to report its third-quarter 2024 results on Oct. 30.The Zacks Consensus Estimate for earnings is pegged at $1.15 per share, unchanged in the past 30 days. This indicates a decline of 0.86% from the figure reported in the year-ago quarter. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Cognizant expects third-quarter 2024 revenues between $4.89 billion and $4.96 billion, indicating a decline of 0.2% to an increase of 1.3% (an increa ...
Exploring Analyst Estimates for Cognizant (CTSH) Q3 Earnings, Beyond Revenue and EPS
ZACKS· 2024-10-28 14:21
Analysts on Wall Street project that Cognizant (CTSH) will announce quarterly earnings of $1.15 per share in its forthcoming report, representing a decline of 0.9% year over year. Revenues are projected to reach $5 billion, increasing 2.2% from the same quarter last year. The consensus EPS estimate for the quarter has undergone an upward revision of 0.2% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates durin ...